Biological/targeted synthetic <scp>DMARDs</scp> do not arrest bone loss in patients with rheumatoid arthritis: a long‐term multicenter observational study

Even when RA activity was controlled with b/tsDMARDs, BMD still decreased. This study emphasizes the importance of considering osteoporosis as an independent aspect of RA, beyond inflammation control.